Sanofi Adr (SNY)

Sep 27, 2026

Sanofi (SNY) stock price, news, quote and history - Yahoo Finance Australia

Sep 27, 2026

Sep 25, 2026

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 25, 2026

Sep 25, 2026

Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - GlobeNewswire Inc.

Sep 25, 2026

Sep 23, 2026

The Best Healthcare Stocks to Buy - Morningstar

Sep 23, 2026

Sep 22, 2026

Is Regeneron Stock a Bargain Below $800? - The Motley Fool

Sep 22, 2026

Sep 22, 2026

DPT Vaccine Market Size Report 2026: Projected to Reach 5,281.80 Million USD, Growing at a CAGR of 0.49% - note.com

Sep 22, 2026

Sep 17, 2026

Sanofi transfers 20 medicines to Cheplapharm partnership - grafa.com

Sep 17, 2026

Sep 16, 2026

Sanofi: Stronger Launches And A New R&D Reset Keep The Re-Rating Case Alive (NASDAQ:SNY) - Seeking Alpha

Sep 16, 2026

Sep 14, 2026

Sanofi stock edges higher as Deutsche Bank reiterates Buy rating - AD HOC NEWS

Sep 14, 2026

Sep 10, 2026

Sanofi partners with USA Pickleball to launch "Serve Up Protection" campaign to help protect older adults from COVID-19 with NUVAXOVID - Finviz

Sep 10, 2026

Sep 09, 2026

RBC Capital initiates Sanofi stock at Sector Perform on transition risks - Investing.com Canada

Sep 09, 2026

Sep 04, 2026

Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.

Sep 04, 2026

Aug 31, 2026

Sanofi ADSADR Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 31, 2026

Aug 27, 2026

European ADRs Slipped In US Trading Late Thursday Morning - Finimize

Aug 27, 2026

Aug 27, 2026

Sanofi-ADR (NASDAQ:SNY): A Dividend Quality Candidate with Solid Profitability - ChartMill

Aug 27, 2026

Aug 21, 2026

Sanofi stock holds firm as workforce shake-up follows strong Q2 2026 - ad-hoc-news.de

Aug 21, 2026

Aug 21, 2026

Sanofi stock steadies after strong Q2 2026 and upgraded guidance - Ad-hoc-news.de

Aug 21, 2026

Aug 20, 2026

Sanofi stock steadies as upgraded 2026 guidance follows strong Q2 momentum - AD HOC NEWS

Aug 20, 2026

Aug 18, 2026

European ADRs Drift Lower In US Trading - Finimize

Aug 18, 2026

Aug 18, 2026

Sanofi stock climbs as MenQuadfi approval and cuts reshape the story - Ad-hoc-news.de

Aug 18, 2026

Aug 18, 2026

Sanofi stock edges higher as MenQuadfi approval and workforce reshaping define mid-August story - Ad-hoc-news.de

Aug 18, 2026

Aug 17, 2026

Sanofi's New Leadership Faces Looming Patent Cliff - Morningstar

Aug 17, 2026

Aug 14, 2026

6 Undervalued Stocks That Crushed Earnings - Morningstar

Aug 14, 2026

Aug 13, 2026

Resilient Sanofi stock edges higher as Q2 2026 growth and R&D reshuffle shape outlook - Ad-hoc-news.de

Aug 13, 2026

Aug 13, 2026

Sanofi stock holds steady as India unit boosts profit and secures tax refund - Ad-hoc-news.de

Aug 13, 2026

Aug 06, 2026

Trump considers order on autism and vaccines: which stocks are most exposed? - Investing.com

Aug 06, 2026

Aug 04, 2026

Nurix earns $10m milestone as Sanofi starts STAT6 degrader trial - Investing.com Nigeria

Aug 04, 2026

Aug 02, 2026

ETFs Investing in Sanofi SA Sponsored ADR Stocks - TradingView

Aug 02, 2026

Jul 31, 2026

Key facts: Sanofi SA Sponsored ADR files H1 2026; halts three drugs - TradingView

Jul 31, 2026

Jul 30, 2026

What's behind Sanofi's latest 5.4% stock pullback? - tradersunion.com

Jul 30, 2026

Jul 30, 2026

European ADRs Jump In US Trading As Banks Lead - Finimize

Jul 30, 2026

Jul 21, 2026

SNY Stock Quote Price and Forecast - CNN

Jul 21, 2026

Jul 17, 2026

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings - Sahm

Jul 17, 2026

Jul 14, 2026

Ericsson Stock Slumps As ADR Underperformance Weighs On Traders - StocksToTrade

Jul 14, 2026

Jul 13, 2026

SANOFI-ADR (NASDAQ:SNY): A Decent Value Stock With Strong Fundamentals and an Undervalued Profile - ChartMill

Jul 13, 2026